Mayer Fishman
Impact in
- Immunology top 1%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Renal cell carcinoma treatment 54
- Prostate Cancer Treatment and Research 9
- Oncology 64
- Cancer Immunotherapy and Biomarkers 42
- Co-authors
- Dmitry I. Gabrilovich (10 shared papers)Scott Antonia (12 shared papers)Yulia Nefedova (3 shared papers)Simon Sherman (2 shared papers)Richard M. Lush (6 shared papers)Paul B. Jacobsen (11 shared papers)Mary Dunn (5 shared papers)Xingyu Wang (1 shared paper)
- Journals
- Journal of Clinical Oncology (42 papers)Clinical Cancer Research (9 papers)Cancer (6 papers)Cancer Research (5 papers)Clinical Genitourinary Cancer (5 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Mayer Fishman
145 papers receiving 6.5k citations
Mayer Fishman's Hit Papers
Peers
Comparison fields: 5 of 130
- Immunology 2.2k
- Oncology 2.6k
- Cancer Research 758
- Pulmonary and Respiratory Medicine 1.5k
- Molecular Biology 1.7k
Countries citing papers authored by Mayer Fishman
This map shows the geographic impact of Mayer Fishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayer Fishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayer Fishman more than expected).
Fields of papers citing papers by Mayer Fishman
This network shows the impact of papers produced by Mayer Fishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayer Fishman. The network helps show where Mayer Fishman may publish in the future.
Co-authors
The 25 scholars most cited alongside Mayer Fishman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma Hit paper breakdown → | 2017 | 679 |
| 2 | Lipid accumulation and dendritic cell dysfunction in cancer Hit paper breakdown → | 2010 | 593 |
| 3 | 2006 | 475 | |
| 4 | 2007 | 366 | |
| 5 | 2013 | 307 | |
| 6 | Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial Hit paper breakdown → | 2018 | 279 |
| 7 | 2010 | 246 | |
| 8 | 2007 | 198 | |
| 9 | 2013 | 188 | |
| 10 | 2015 | 155 | |
| 11 | 2011 | 118 | |
| 12 | 2019 | 115 | |
| 13 | 2015 | 108 | |
| 14 | 2018 | 104 | |
| 15 | 2016 | 95 | |
| 16 | 2012 | 93 | |
| 17 | 2013 | 82 | |
| 18 | 2004 | 78 | |
| 19 | 2015 | 66 | |
| 20 | 2014 | 65 |
About Mayer Fishman
Mayer Fishman is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Immunology and Surgery, having authored 150 papers that have together received 6.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (54 papers), Cancer Immunotherapy and Biomarkers (42 papers), Immunotherapy and Immune Responses (17 papers), Bladder and Urothelial Cancer Treatments (15 papers), Cancer Genomics and Diagnostics (12 papers), Renal and related cancers (9 papers), Prostate Cancer Treatment and Research (9 papers) and Economic and Financial Impacts of Cancer (8 papers). The work is most often cited by research in Immunology (2.2k citations), Oncology (2.6k citations), Cancer Research (758 citations), Pulmonary and Respiratory Medicine (1.5k citations) and Molecular Biology (1.7k citations). Mayer Fishman has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Dmitry I. Gabrilovich, Scott Antonia, Yulia Nefedova, Simon Sherman, Richard M. Lush, Paul B. Jacobsen, Mary Dunn, Xingyu Wang, Amer A. Beg and Heather Jim. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer, Cancer Research and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.